Background: Vitamin D deficiency (VDD) is prevalent in polycystic ovary syndrome (PCOS) and the relationship between dyslipidemia vitamin status close. This meta-analysis was to evaluate effect of (alone or with co-supplementation) on lipid profile PCOS patients.

Women are usually diagnosed when in their 20s or 30s, but PCOS may also affect teenage girls. The symptoms often begin when a girl's periods start. Women with this disorder often have a mother or sister who has symptoms similar to those of PCOS. The main features are obesity, anovulation or amenorrhea, acne, and excessive hair growth. It is thought to be one of the leading causes of female infe...

background: polycystic ovary syndrome (pcos) is the most common chronic endocrine disorder. it has significant and diverse clinical consequences including reproductive, metabolic, and psychological morbidities as well as predisposition to malignancies. it is unclear how women with pcos experience symptoms of this syndrome. objectives: the aim of this study was to clarify the dimensions and comp...

conclusions while the expression of visfatin and resistin may be upregulated in women with pcos, it is not translated at serum level. results serum levels of resistin were higher among both obese and normal-weight women with pcos in comparison with the controls (2.36 and 1.58 ng/ml in normal-weight women with pcos and controls, respectively; and 2.10 and 1.91 ng/ml in obese women with pcos and ...

background mean platelet volume (mpv) is generally accepted as a new marker of cardiovascular disease risk in several studies. objectives this study aimed to determine the association of mpv with androgen hormones and insulin resistance (ir) in nonobese patients with polycystic ovary syndrome (pcos). patients and methods a total of 136 patients with newly diagnosed reproductive-age pcos (regard...

Obesity is worldwide spreading epidemic and deleteriously affects the metabolic reproductive functions of females. The results therapeutic lines provided for obese citrate-resistant women with polycystic ovary syndrome (CCR-POCS) were variable discrepant.

OBJECTIVE To assess the effectiveness of metformin in improving clinical and biochemical features of polycystic ovary syndrome. DESIGN Systematic review and meta-analysis. DATA SOURCES Randomised controlled trials that investigated the effect of metformin compared with either placebo or no treatment, or compared with an ovulation induction agent. SELECTION OF STUDIES 13 trials were includ...

BACKGROUND Impaired insulin activity in women with polycystic ovary syndrome might differ from that seen in type 2 diabetes mellitus without polycystic ovary syndrome. This study was designed to compare the effects of treatment with metformin, saxagliptin, and their combination in newly diagnosed women with type 2 diabetes mellitus and polycystic ovary syndrome in China. METHODS A total of 75...